← FDA DRUG APPROVALS

FDA ANDA · ANDA080403

CHLORPROMAZINE HYDROCHLORIDE

Sponsor: PUREPAC PHARM

APPLICATION
ANDA080403
TYPE
ANDA
LATEST ACTION
1982-06-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 10MG · TABLET · ORAL
CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 50MG · TABLET · ORAL
CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 200MG · TABLET · ORAL
CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 100MG · TABLET · ORAL
CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 25MG · TABLET · ORAL

Approval history

1982-06-28Manufacturing (CMC) · Supplement 35AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →